Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to test the hypothesis that amlodipine plus atorvastatin given in a single tablet (Caduet), compared with amlodipine alone (Norvasc), has a stronger effect in protection of arterial structure and function.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Arterial and Arteriolar Disorders

NCT number NCT01922687
Study type Interventional
Source Shanghai Institute of Hypertension
Contact Yan Yang
Phone 64370045
Email jesuisyang@163.com
Status Recruiting
Phase Phase 4
Start date April 2011
Completion date December 2014